Cefalexim

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefalexim

The drug known as Cefalexim is an established, widely used antibiotic for oral administration. It is classified as a first-generation cephalosporin and is an essential tool in systemic antibacterial therapy.

Property Description
Active Ingredient Cephalexin (INN)
Form Capsules, Tablets, Oral Suspension
Pharmacological Class beta-Lactam / First-Generation Cephalosporin
Common Purpose Resolving susceptible bacterial infections
Origin Semisynthetic

Defining the Core Antibiotic Entity and Classification

Cefalexim is the medicinal product name for the active pharmaceutical ingredient Cephalexin, a semisynthetic beta-lactam antibiotic. Cephalexin belongs to the cephalosporin class and is utilized for both outpatient and inpatient care, reflecting its foundational role in medicine.

As a first-generation cephalosporin, Cephalexin holds a specific niche in antibacterial treatment. Its classification is characterized by its stability against stomach acid, a feature that ensures effective oral administration. The drug functions as a bactericidal agent, meaning it actively kills susceptible bacteria through the inhibition of cell-wall synthesis.


Available Forms and Therapeutic Significance

The availability of Cefalexim in various pharmaceutical preparations, including rigid capsules, compressed tablets, and powder for oral suspension, ensures delivery across diverse patient needs. The compound is a single-ingredient product, containing only Cephalexin (typically as the monohydrate) alongside inert excipients.

Cephalexin is recognized as an essential medicine, underscoring its therapeutic value and reliability as an anti-infective agent. The general purpose of Cefalexim is to reliably eliminate the bacterial invaders susceptible to its action, thus facilitating the patient's recovery from infection.

Regulatory References

  1. Cephalexin - StatPearls - NCBI Bookshelf

What side effects are possible with Cefalexim?

Cefalexim: Possible side effects and safety information

Adverse Reactions and Frequencies

Like all medicines, Cefalexim can cause side effects. Reactions are typically categorized by frequency based on available clinical and post-marketing data.

Frequency System-Organ Class Examples
Common (ge 1/100 to <1/10) Diarrhea, Nausea.
Uncommon (ge 1/1,000 to <1/100) Eosinophilia, Rash, Urticaria, Reversible increase in liver enzymes (ASAT/ALAT).
Rare (ge 1/10,000 to <1/1,000) Reversible Interstitial Nephritis, Pseudomembranous colitis, Anaphylactic reaction, Hepatitis, Haemolytic anemia, Stevens-Johnson Syndrome.
Not Known Seizures, Hallucinations, Confusion, Encephalopathy, Acute Generalized Exanthematous Pustulosis (AGEP).

Serious Adverse Reactions

Serious reactions that warrant immediate medical attention, though rare, include anaphylaxis and other severe hypersensitivity reactions (e.g., Toxic Epidermal Necrolysis), severe gastrointestinal disorders like Pseudomembranous Colitis (Clostridium difficile-associated diarrhea), and rare hematologic issues like Hemolytic Anemia. Neurotoxicity, including seizures, has been reported, particularly in cases of dose accumulation.

Safety Restrictions and Population Considerations

Cefalexim is contraindicated in individuals with a known allergy to cefalexim or other cephalosporin antibiotics. Caution is required in patients with a history of penicillin allergy due to potential cross-sensitivity.

Renal Impairment: Patients with reduced kidney function (renal impairment) require specific dose adjustment because the drug is primarily cleared by the kidneys. Failure to adjust the dose can lead to high concentrations in the blood, increasing the risk of neurotoxicity (e.g., seizures).

Interference with Diagnostics: The drug may cause a false-positive direct Coombs test and can interfere with some non-enzymatic urine glucose tests.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documents describe the primary manifestations of Cefalexim overdose as gastrointestinal effects, including nausea, vomiting, diarrhoea, and epigastric distress. Additionally, haematuria (blood in urine) is a documented clinical finding.

Immediate Medical Attention is required if severe manifestations occur. These life-threatening signs include collapse, seizure, trouble breathing, or an inability to be awakened. In such severe scenarios, the regulator mandates calling emergency services immediately and contacting a Poison Control center.

The documented management strategy involves providing general supportive care. For severe overdosage, close clinical and laboratory monitoring of renal, hepatic, haematological function, and coagulation status is necessary until the patient is stable. No specific antidote is documented in the regulatory prescribing information. Furthermore, while gastrointestinal decontamination may be considered only if the amount ingested is 5 to 10 times the normal total daily dose, procedures such as haemodialysis are not established as beneficial. Haematuria without renal impairment has been specifically noted in overdose reports concerning children.

Therapeutic Uses of Cefalexim

What Cefalexim Treats: Main Uses and Benefits

Cefalexim is a commonly used oral antibiotic applied to help manage susceptible bacterial infections, offering symptomatic relief and may help reduce the risk of acute disease progression. Its application is centered on conditions where symptoms are driven by a bacterial pathogen, providing systemic support to ease patient distress. This medication is used across domains where additional symptomatic support is needed.

The therapeutic benefit is generally associated with conditions presenting with systemic or localized discomfort, encompassing infections of the skin (like cellulitis and abscesses), the upper respiratory tract (such as strep throat and tonsillitis), the ears (otitis media), and the urinary tract (including cystitis). This treatment is commonly applied in scenarios where symptoms become more noticeable, may be relevant for easing discomforts like fever, localized pain, and swelling.

“Cefalexim is considered relevant in contexts involving heightened systemic burden, supporting general well-being during symptomatic phases.”

Quick Fact: Support for Symptoms Related to Pain and Fever This medication is commonly used during acute phases when fever and localized pain (e.g., severe sore throat or dysuria) intensify, assisting with maintaining functional stability, which helps ease the overall symptom load.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Cefalexim?

This section outlines the officially documented eligibility and non-eligibility criteria for Cefalexim (Cephalexin), based strictly on regulatory prescribing information.


Contraindications and Exclusions

Cefalexim is contraindicated and must not be used by patients with a known history of hypersensitivity (allergy) to Cephalexin or to any other drug within the cephalosporin class of antibiotics. Absolute exclusion may also apply to patients with acute porphyria or specific hereditary metabolic disorders (e.g., total lactase deficiency) if excipients in the formulation make it unsuitable.


Conditional Use and Age-Group Eligibility

Age-Group Eligibility: Use is established for adults and generally for pediatric patients over 1 year of age. Use in older adults is established, but eligibility requires assessment of renal function.

Conditional Restrictions: Patients with markedly impaired renal function (e.g., severe kidney impairment) are eligible only for restricted use and require specific dosage adjustment due to delayed drug clearance. Caution is also required for patients with a history of penicillin allergy due to documented cross-sensitivity or a history of certain gastrointestinal diseases like colitis.

Reproductive Status: Use during pregnancy (often Category B) and lactation is generally permitted, but requires caution as the drug is known to be excreted into human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cefalexim has documented interactions with specific medications and diagnostic tests, primarily related to its elimination from the body. It is essential to inform your healthcare provider about all prescription drugs, over-the-counter products, and supplements you are taking.


Documented Drug Interactions

Interacting Product/Class Interaction Mechanism/Result Recommendation
Probenecid (Anti-gout) Inhibits the renal excretion of cefalexim, which may increase cefalexim levels. Co-administration is not recommended due to increased side effect risk.
Metformin (Anti-diabetes) Cefalexim decreases the renal clearance of metformin, leading to higher metformin plasma concentrations. Careful patient monitoring and potential dose adjustment of metformin are recommended.
Oral Contraceptives (Hormonal) Limited data suggest a potential for decreased effectiveness. Additional non-hormonal contraception may be necessary.
Loop Diuretics (e.g., furosemide) May increase the risk of kidney-related side effects. Use with caution and monitoring.

Laboratory Test Interference

Cefalexim administration may result in a false-positive reaction for glucose in the urine when using copper reduction methods (such as Benedict’s solution, Fehling’s solution, or Clinitest® tablets). This can complicate blood sugar monitoring for patients with diabetes.

Other Interactions

For patients with renal impairment, delayed clearance of cefalexim may occur, requiring close monitoring for toxicity. Taking products containing zinc may decrease cefalexim absorption and reduce its effectiveness; a minimum time gap between doses is often advised.

Mechanism of Action

How Cefalexin Interferes with Bacterial Proliferation

Cefalexin acts by targeting the enzyme machinery that bacteria utilize for cell wall assembly. It functions as a specialized inhibitor that binds to and inactivates Penicillin-Binding Proteins (PBPs), which are transpeptidases essential for cross-linking the peptidoglycan chains that form the rigid, protective layer of the bacterial cell.


Mechanism Leading to Bacterial Cell Lysis

The irreversible inhibition of cell wall construction results in a critical structural defect in the bacterial envelope. Without the necessary support provided by a complete and functional wall, the bacteria are unable to withstand their internal osmotic pressure, leading to the rupture of their cell membrane (lysis). This cellular consequence is categorized as a bactericidal effect, inducing the destruction and lysis of susceptible microbial cells.

Dosage and Administration Information

How to Use Cefalexim: Administration Guidelines

Cefalexim is a first-generation cephalosporin antibiotic used exclusively via the oral route of administration. It is available across multiple dosage forms, including capsules, tablets, and powder for oral suspension in specific, approved strengths.


Standard Dosing and Frequency

The medicine is typically administered in divided doses throughout the day, commonly at intervals of every 6 or every 12 hours. The standard adult dosing range spans from 1 gram to 4 grams daily in divided doses, with a maximum daily dose not exceeding 4 grams. The most frequent regimens are 250 mg every 6 hours or 500 mg every 12 hours.


Administration Context and Course Duration

Cefalexim may be taken with or without food, providing flexibility in the timing of administration. Solid forms (tablets and capsules) should be swallowed whole with water. For the oral suspension, the liquid must be shaken well before each measured use.

The typical course of therapy ranges from 7 to 14 days, though specific infections, such as those caused by beta-hemolytic streptococci, require a minimum administration period of 10 days.


Population-Specific Use and Missed Doses

Dose adjustment is required for adult patients who exhibit impaired renal function, specifically when creatinine clearance is below 30 mL/min. Pediatric dosing is determined based on body weight, starting with a general range of 25 to 50 mg/kg/day in equally divided doses.

If a dose is missed, it should be taken as soon as remembered; however, if it is almost time for the next scheduled dose, the missed dose is skipped to prevent a double dose.

Recent Clinical Evidence

Cefalexim (cephalexin), a first-generation cephalosporin, remains a widely used and effective oral antibiotic, primarily for infections caused by susceptible Gram-positive bacteria, such as Streptococci and methicillin-susceptible Staphylococcus aureus (MSSA).

Efficacy in Skin and Soft Tissue Infections (SSTIs)

Clinical guidelines continue to recommend cefalexim as a first-line therapy for non-purulent cellulitis and other uncomplicated SSTIs where infection with Methicillin-Resistant Staphylococcus aureus (MRSA) is not suspected. Recent trials and guidelines emphasize that for simple cellulitis without an abscess, the addition of a drug targeting MRSA (such as trimethoprim-sulfamethoxazole) to cefalexim did not show improved outcomes compared to cefalexim alone. This reinforces its role in infections primarily caused by Streptococcus species and MSSA. Treatment durations typically range from 5 to 10 days, depending on the infection's severity and location.

Alternative Dosing and Resistance

There is ongoing research, including recent clinical trials, investigating the use of high-dose oral cefalexim for cellulitis, hypothesizing that higher doses might reduce treatment failure rates and the need for subsequent hospitalization. This is a potential area for future updates in standard prescribing practice. A major consideration in current practice is that cefalexim is not effective against MRSA, which limits its use in areas with high prevalence of community-associated MRSA (CA-MRSA).

Use in Dentistry and Prophylaxis

Cefalexim is also effective in the treatment of certain dental infections, especially when combined with a beta-lactamase inhibitor (e.g., clavulanic acid) to broaden its spectrum. Studies suggest that this combination may be as effective as other commonly prescribed dental antibiotics, with comparable clinical improvement rates. Additionally, it remains an established option for antibiotic prophylaxis in specific high-risk patients with a non-severe penicillin allergy undergoing certain dental or surgical procedures, in line with current endocarditis prevention guidelines.

Frequently Asked Questions (FAQ)

Common questions about Cefalexim (FAQ)


Q: How quickly does Cefalexim typically start working?

A: Official pharmacokinetic data indicates that the onset of action (the point at which the drug begins to work) is generally not precisely defined following oral administration. However, studies show that Cefalexim typically reaches its peak concentration in the bloodstream within about one hour after it is taken. The medicine is designed to begin killing susceptible bacteria shortly after absorption.


Q: Do studies suggest Cefalexim is effective against strep throat?

A: Yes, regulatory documents and official indications for Cefalexim include the treatment of certain respiratory tract infections, specifically streptococcal pharyngitis (commonly known as strep throat). This use is indicated when the infection is caused by susceptible strains of bacteria.


Q: Why do some people experience yeast infections when taking Cefalexim?

A: Official documentation lists oral or vaginal thrush (a type of yeast infection) as a common side effect of Cefalexim. This reaction is generally related to the way broad-spectrum antibiotics can temporarily alter the body's natural balance of microorganisms (such as bacteria and yeast).


Q: Does Cefalexim have any known interactions with birth control pills?

A: Official sources generally state that Cefalexim does not stop hormonal contraceptives from working. However, if the drug causes severe diarrhea that lasts for more than 24 hours, the potential for reduced effectiveness of oral contraceptive pills is noted in patient information.


Q: Is Cefalexim used for urinary tract infections (UTIs)?

A: Yes, Cefalexim is officially approved to treat genitourinary tract infections when they are caused by specific, susceptible bacteria. This class of infections includes many types of urinary tract infections (UTIs).


Q: How long does Cefalexim stay in the body after the last dose?

A: In individuals with normal kidney function, the official elimination half-life of Cefalexim is approximately one-half to one hour. The body generally requires about five half-lives to clear most of the drug, meaning it is typically eliminated within several hours after the final dose.


Q: Is it possible to take Cefalexim while breastfeeding?

A: Official sources indicate that it is generally considered acceptable to take Cefalexim while breastfeeding. Only trace amounts of the drug are known to pass into human breast milk. Use during lactation requires caution and assessment by a healthcare provider.


Q: Are there specific symptoms that might indicate Cefalexim isn't working?

A: Official patient information advises that a lack of improvement in symptoms after two to three days of treatment may indicate the medicine is not working as expected. Also, a worsening of the condition warrants seeking clarification from a healthcare provider.


Q: What should a person know about taking Cefalexim if they have kidney issues?

A: Cefalexim is primarily cleared by the kidneys, so individuals with impaired kidney function require a specific dose adjustment. This is necessary because failure to adjust the dose can lead to an accumulation of the drug in the body, which increases the potential for adverse effects.


Q: Is Cefalexim generally safe to take with common vitamins or supplements?

A: There is a documented interaction with zinc supplements and products containing zinc, which may reduce the absorption and effectiveness of Cefalexim. Official information advises a minimum time gap between doses of Cefalexim and zinc-containing products. Information on interactions with other common vitamins or supplements is generally not specified.


Q: Why is Cefalexim sometimes prescribed for dental infections?

A: Cefalexim is prescribed for certain dental infections because it is effective against the susceptible bacteria commonly found in the mouth that cause abscesses and gum infections. It is also an established alternative antibiotic choice for some patients who have a documented allergy to penicillin.


Q: What is the usual storage recommendation for Cefalexim capsules?

A: Official patient information for Cefalexim capsules instructs storage at a Controlled Room Temperature (typically 20 C to 25 C), in their original container, and away from moisture. All forms of the medication are required by government labeling to be stored out of the sight and reach of children.


Q: Can Cefalexim cause dizziness or drowsiness?

A: Yes, official documentation reports that side effects may include dizziness and drowsiness in some patients. The possibility is noted in official safety information, with some sources categorizing these as less common effects.


Q: Does Cefalexim interact with alcohol consumption, according to official sources?

A: Official prescribing information generally does not list a direct drug-to-drug interaction between Cefalexim and alcohol. However, alcohol consumption may enhance some of the drug's known side effects, such as nausea or dizziness.


Q: Is it normal to feel tired while taking Cefalexim?

A: Tiredness (fatigue) or generalized weakness is listed in official documentation as a reported side effect of Cefalexim. The frequency and severity of this effect can vary among individuals.

How should Cefalexim be stored and disposed of?

The official storage requirements for Cefalexin differ by dosage form, and all rules are mandated by regulatory authorities to ensure product stability.

Storage Requirements

Dosage Form Mandatory Storage Condition In-Use Stability Limit
Capsules/Tablets Store at Controlled Room Temperature (20 C to 25 C) in a tight container. None specified
Reconstituted Suspension Store in a refrigerator (2 C to 8 C). Do not freeze. Must be discarded after 14 days.

General Handling and Disposal

All forms of the medication must be stored out of the sight and reach of children, as required by government labeling. The liquid suspension container must be kept tightly closed during storage. Disposal of any unused or expired product must be carried out according to local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefalexim found in:

A-Z Index: